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The ROCK-I serine/threonine protein kinase mediates the
effects of RhoA to promote the formation of actin stress
ﬁbres and integrin-based focal adhesions. ROCK-I phos-
phorylates the unconventional G-protein RhoE on multiple
N- and C-terminal sites. These phosphorylation events
stabilise RhoE, which functions to antagonise RhoA-in-
duced stress ﬁbre assembly. Here, we provide a molecular
explanation for multi-site phosphorylation of RhoE from
the crystal structure of RhoE in complex with the ROCK-I
kinase domain. RhoE interacts with the C-lobe aG helix of
ROCK-I by means of a novel binding site remote from its
effector region, positioning its N and C termini proximal to
the ROCK-I catalytic site. Disruption of the ROCK-I:RhoE
interface abolishes RhoE phosphorylation, but has no
effect on the ability of RhoE to disassemble stress ﬁbres.
In contrast, mutation of the RhoE effector region attenu-
ates RhoE-mediated disruption of the actin cytoskeleton,
indicating that RhoE exerts its inhibitory effects on ROCK-I
through protein(s) binding to its effector region. We pro-
pose that ROCK-I phosphorylation of RhoE forms part of a
feedback loop to regulate RhoA signalling.
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Introduction
Rho family G proteins, the functions of which are mediated
by a variety of effector molecules, are critical regulators of
cell motility, polarity, adhesion, cytoskeletal reorganisation,
proliferation and apoptosis (Jaffe and Hall, 2005; Ridley,
2006). The related serine/threonine protein kinases ROCK-I
(ROKb/
p160ROCK) and ROCK-II (ROKa/Rho-kinase) (Kimura
et al, 1996; Leung et al, 1996; Amano et al, 1997, 2000; Riento
and Ridley, 2003) were the ﬁrst Rho effectors to be discov-
ered, being initially characterised for their roles in mediating
the formation of RhoA-induced stress ﬁbres and focal adhe-
sions. ROCK kinases elicit these effects through the phos-
phorylation of myosin light chain (MLC) and the MLC
phosphatase subunit MYPT1, thereby enhancing acto-myosin
contractility (Amano et al, 1996; Kimura et al, 1996).
RhoA-induced stress ﬁbre and focal adhesion formation
are inhibited by two atypical members of the Rho family,
Rnd1 and RhoE (also termed Rnd3) (Guasch et al, 1998;
Nobes et al, 1998; Nobes and Hall, 1999). The direct mole-
cular targets of RhoE responsible for exerting these effects are
unknown, but appear to be mediated through RhoE-induced
antagonism of RhoA activation of ROCK-I-mediated signal-
ling. This notion is supported by studies showing that RhoE’s
capacity to promote stress ﬁbre disassembly and increased
cell motility is associated with decreased MYPT1 phosphor-
ylation, resembling the effects of small molecule inhibitors of
ROCK kinases (Guasch et al, 1998; Riento et al, 2003). There
is evidence that RhoE-mediated inhibition of RhoA signalling
occurs either through inactivation of RhoA and/or regulation
of the RhoA effector ROCK. RhoE, similarly to Rnd1, stimu-
lates p190 RhoGAP to reduce intracellular levels of RhoA-GTP
(Wennerberg et al, 2003). However, RhoE also binds ROCK-I
directly, and is phosphorylated by the kinase on multiple sites
within its N and C termini, increasing RhoE stability and
altering its cellular localisation (Riento et al, 2005a). Growth
factor-induced ROCK-I-mediated phosphorylation of RhoE
Ser11 correlates with stress ﬁbre disassembly, and its dephos-
phorylation coincides with their reappearance (Riento et al,
2005a).
In contrast to the canonical mode of G-protein activity and
regulation, RhoE and the related Rnd1 and Rnd2 G proteins
are defective as GTPases even in the presence of RhoGAPs
(Foster et al, 1996; Guasch et al, 1998; Nobes et al, 1998;
Nobes and Hall, 1999; Riento et al, 2005b; Chardin, 2006).
Moreover, as Rnd1, Rnd2 and RhoE bind GTP 100-fold more
tightly than GDP, in vivo they exist constitutively in the
GTP-bound form (Foster et al, 1996). Regulation of these
G proteins is exerted at the level of gene expression (Hansen
et al, 2000; Riento et al, 2003; Ongusaha et al, 2006),
phosphorylation and controlled protein degradation (Riento
et al, 2005a).
To understand the molecular basis for ROCK-I-catalysed
multi-site phosphorylation of RhoE, we have determined the
crystal structure of RhoE in complex with the kinase/dimer-
isation domains of ROCK-I. RhoE interacts with the C-term-
inal lobe of the ROCK-I kinase domain, presenting its N and C
termini in proximity to the kinase catalytic site facilitating
their phosphorylation. The ROCK-I interaction sites of
RhoE are remote from a so-called ‘effector’ region, which
mediates all small G-protein/effector interactions thus far
characterised. The ROCK-I:RhoE structure therefore has
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3175implications for understanding how G proteins recognise
proteins independent of their effector/switch regions.
Signiﬁcantly, although mutants of RhoE that disrupt ROCK-I
binding are as effective as wild-type RhoE in inducing loss of
stress ﬁbres, mutations within the effector region of RhoE
profoundly inhibit this response. These data indicate that
RhoE mediates an indirect inhibitory effect on ROCK-I
through effector site-mediated interactions with regulators
of RhoA signalling.
Results
ROCK-I kinase domain forms a 1:1 complex with RhoE
A region of ROCK-I (residues 1–420) incorporating both the
kinase (residues 70–404) and the N-terminal dimerisation
domains (residues 1–69) (Doran et al, 2004; Jacobs et al,
2006) was deﬁned earlier to be necessary and sufﬁcient for
direct RhoE interactions (Riento et al, 2003). Signiﬁcantly,
this region of ROCK-I is incapable of binding RhoA (Riento
et al, 2003). To obtain protein boundaries optimised for
crystallisation, guided by tryptic analysis and the published
ROCK-I structure, we removed an additional 14 residues from
the ROCK-I C terminus (ROCK-I
1 406). This shorter ROCK-I
fragment interacted with RhoE indistinguishably from
ROCK-I
1 420 (Supplementary Figure S1A), and microinjection
of both ROCK-I proteins induced stress ﬁbres in Swiss 3T3
cells (Supplementary Figure S1B). We co-crystallised
ROCK-I
1 406 in complex with RhoE-GTP/Mg
2þ (residues
1–200) in the presence of AMP-PNP/Mg
2þ. The complex
crystallised in space group P6522, and the structure was
determined at 3.7A ˚ resolution. Diffraction data quality was
compromised by a long cell axis and radiation damage.
Moreover, only a few crystals diffracted to an intrinsic
resolution limit of 3.7A ˚. The structure was solved by mole-
cular replacement using the previously determined structures
of the ROCK-I kinase domain (Jacobs et al, 2006) and RhoE
(Garavini et al, 2002) (Table I and Materials and methods).
The asymmetric unit comprises a dimer of ROCK-I, with each
kinase subunit engaging an individual RhoE molecule
(Figure 1). Examination of molecular packing within the
unit cell indicated that this inter-molecular interaction corre-
sponds to the only signiﬁcant ROCK-I:RhoE contact, and
therefore represents the biologically relevant ROCK-I:RhoE
interface (Supplementary Figure S2A). Application of strict
NCS restraints during reﬁnement, combined with an 80%
solvent content, resulted in electron density maps of excep-
tional quality (Supplementary Figure S3A). Although not
present in the individual search models, nucleotide density
was discernible in every protein molecule (Supplementary
Figure S3C and D), and these ligands were reﬁned with full
occupancy. In RhoE, electron density is well deﬁned for
residues Gln20 to Lys200, whereas in ROCK-I residues
6–404 are similarly well resolved. Calculation of simulated
annealing OMIT maps indicated that the reﬁned structure
was free of model bias (Supplementary Figure S3B).
RhoE comprises a canonical GTP-binding domain with
extended N and C termini relative to most other Rho family
members (Figure 1). In the crystal structures of isolated
RhoE, the N- and C-terminal regions (19 and 43 residues,
respectively) were absent (Fiegen et al, 2002; Garavini et al,
2002). However, in our crystallised complex, the N-terminal
residues of RhoE were included. Importantly, Ser7 and Ser11
of RhoE are sites of ROCK-I phosphorylation (Riento et al,
2005a).
The N-terminal a-helical dimerisation domain of ROCK-I
organises two kinase domains in a head-to-head conﬁgura-
tion (Figure 1) (Jacobs et al, 2006; Yamaguchi et al, 2006).
Accounting for its requirement for catalytic activity (Leung
et al, 1996), the dimerisation domain incorporates and sta-
bilises the hydrophobic motif located C-terminal to the kinase
domain, a site of regulatory phosphorylation in diverse AGC
family kinases (Pearl and Barford, 2002; Gold et al, 2006;
Jacobs et al, 2006; Yamaguchi et al, 2006). Similarly to the
isolated ROCK-I and -II structures (Jacobs et al, 2006;
Yamaguchi et al, 2006), the kinase domain of ROCK-I in
complex with RhoE adopts a conformation consistent with
that of a catalytically active kinase (Johnson et al, 1996;
Nolen et al, 2004) (Figure 2A).
RhoE interacts with the C-lobe of ROCK-I independent
of its switch regions
The most striking feature of the ROCK-I:RhoE interface is its
complete independence of the switch I/effector and switch II
regions of RhoE, a mode of G-protein–protein recognition
that contrasts with all previously known G-protein–effector
complexes (Vetter and Wittinghofer, 2001). Regions of RhoE
that interact with ROCK-I lie on the opposite surface of the
Table I Data collection and reﬁnement statistics
ROCK1:RhoE
complex
Data collection statistics
Beamline ID29 ESRF
Wavelength (A ˚) 1.000
Space group P6522
Unit cell (A ˚) a¼152.48
b¼152.48
c¼531.27
Overall Inner shell Outer shell
Resolution (A ˚) 131–3.70 131–11.7 3.90–3.70
Observed reﬂections 150886 4549 22440
Unique reﬂections 39411 1326 5707
Redundancy 3.8 3.4 3.9
Completeness (%) 98.9 91.8 99.9
Rmerge 0.189 0.096 0.420
/I/sIS 8.4 20.7 3.0
Reﬁnement statistics
Reﬂections in
test set
809
Rcryst 0.237
Rfree 0.270
Number of
protein atoms
9131
Number of
ligand atoms
62
Wilson B (A ˚ 2) 75.0
/BS protein (A ˚ 2) 81.7
/BS ligand (A ˚ 2) 108.8
RMSD from ideal geometry
Bond length (A ˚) 0.008
Bond angles (deg) 1.306
Ramachandran
statistic (preferred/
allowed/outliers)
885 (78%)/
76 (15%)/
79 (7%)
Values in brackets are for the highest resolution shell. All measured
data were included in structure reﬁnement.
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between RhoE and ROCK-I are dominated by the a4-b6-a5
module of RhoE that engages with the C-lobe of the kinase,
centred on its aG helix. The kinase’s N-lobe and dimerisation
domain do not participate in RhoE interactions. Residues of
RhoE and ROCK-I mediating these interactions are invariant
in mammalian forms of both proteins (data not shown). The
a4-b6-a5 module of RhoE deﬁnes a shallow channel, con-
tacting the kinase domain such that the kinase aG helix is
aligned parallel to b6, and antiparallel to the a4 and a5
helices of RhoE (Figure 2A). The protein–protein interface
is further augmented by contacts between the tip of the b2/b3
hairpin of RhoE and the aEF/aF loop, preceding aEF helix,
and neighbouring activation segment of the kinase. In total,
around 2500A ˚ 2 solvent accessible surface area is buried at
the protein interface (Figure 2B and C).
Interactions at the ROCK-I:RhoE interface are dominated
by the a5 helix of RhoE and the aEF/aF loop and aG helix of
ROCK-I (Figure 2A). As noted by Fiegen et al (2002), the a5
helix of RhoE is notably richer in nonpolar residues when
compared with other small G proteins, and the contacts
between a5 and the ROCK-I aG helix are entirely hydrophobic
(Figure 3A and B). In ROCK-I, a cluster of exposed residues
extending a hydrophobic ridge on the aG helix (Val284,
Tyr287 and Met291), together with the side chain of Leu246
of the aEF helix, creates a contiguous hydrophobic surface to
engage complementary nonpolar residues (Val192 and
Leu195) of the RhoE a5 helix. Additional contacts contributed
by the a5 helix include the imidazole side chain of His191
donating a hydrogen bond to the amide side chain of Gln249
(aEF helix) and, promoted through a shift of B5A ˚, the
guanidinium side chain of Arg187 of a5 donates hydrogen
bonds to main-chain carbonyls at the C terminus of the aEF
helix. The b6 strand of RhoE contacts the kinase aG helix
through hydrogen bonds between Thr173 (b6) and Ser288
(aG), whereas the side-chain hydroxyl group of Tyr159 at the
N terminus of a4 of RhoE donates a hydrogen bond to the
amide side chain of Asn292 at the C terminus of aG. Finally,
from the b2/b3 loop of RhoE, the Asp67 side chain accepts
hydrogen bonds from the amide side chain of Gln249 (aEF/
aF loop) and main-chain amide of Ala234 of the activation
segment, the only contact between RhoE and the kinase
activation segment. Gln249 becomes available for interac-
tions with both Asp67 (b2/b3 loop) and His191 (a5 helix) of
RhoE following the conformational shift of the aEF/aF loop
(see below).
Figure 1 Overview of ROCK-I:RhoE complex. Each subunit of the
ROCK-I dimer binds one molecule of RhoE, forming a dyad-symme-
trical molecule. The complex dimerises through the dimerisation
domain (pink) of ROCK-I. Structural ﬁgures were created using
PYMOL (www.pymol.org).
Figure 2 RhoE interacts through its a4–b6–a5 module with the
C-lobe of the kinase. (A) View of the ROCK-I:RhoE complex, with
secondary structural elements at the protein interface coloured
cyan. Remainder of ROCK-I in blue and pink (dimerisation domain)
and RhoE in orange with switch I and II coloured red. Surface
representation of RhoE (B) and ROCK-I (C) rotated in opposite
directions to (A) to reveal subunit interface. Colour coding as in (A).
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ROCK-I (Riento et al, 2005a). Residues of RhoE that contact
ROCK-I are poorly conserved in Rnd1 and Rnd2, explaining
their inability to bind ROCK-I (Figure 3C, blue and green
arrowheads). ROCK-II phosphorylates RhoE only weakly, and
direct interactions between ROCK-II and RhoE could not be
detected (Riento et al, 2005a). The regions of ROCK-I that
interact with RhoE are highly conserved in ROCK-II, with only
a conservative substitution of an Asp for Asn292 (see below).
The side chain of Asn292, which contacts Tyr159 of a4
(Figure 3A and B), is also within 3–4A ˚ of the main-chain
carbonyl groups of Tyr174 and Glu176 of RhoE (b6), and it is
therefore possible that the repulsive electrostatic interaction
conferred by the negative charge of an Asp side chain would
destabilise interactions between the two proteins.
ROCK-I:RhoE interactions are facilitated through
localised conformational changes of both proteins
Speciﬁc individual structural elements of ROCK-I and RhoE
that participate at the interface of the complex differ in
conformation to their isolated counterparts (Figure 4).
Although the overall conformation of RhoE in association
with ROCK-I is virtually identical to that in isolation, notably
in the vicinity of the GTP-binding site (overall RMSD of 0.6A ˚
between equivalent Ca atoms to RhoE of PDB code 1m7b),
the tip of the b2/b3 loop, which contacts the aEF/aF loop of
ROCK-I, is shifted relative to all isolated RhoE structures
(Figure 4A). Conformational changes of ROCK-I are mainly
conﬁned to the N terminus of the aEF/aF loop, together with
accompanying small shifts of the Pþ1 loop of the activation
segment (Figure 4B). The aEF/aF loop shifts B5A ˚ relative to
the isolated ROCK-I structure (Jacobs et al, 2006), with the
new position well resolved in the electron density maps.
Facilitating its interaction with RhoE, the aEF/aF loop en-
compasses a four-residue insertion (Gly251–Tyr254) unique
to ROCKs, which protrudes from the kinase domain, buttres-
sing the overlying activation segment N-terminal to the Pþ1
loop (Jacobs et al, 2006). Another difference between the
two ROCK-I structures involves the aB/aC loop of the
N-lobe (Figure 4B). The conformation of this loop in the
Figure 3 Details of ROCK-I:RhoE interface. (A) View of interface formed by the a4–b6–a5 module of RhoE to the aG and aEF helices, aEF/aF
loop and activation segment of ROCK-I. Colour scheme as in Figure 2. (B) Schematic of interface shown in (A). Hydrogen bonds and van der
Waals interactions are indicated by grey and red dashed lines, respectively. ROCK-I and RhoE residue labels are in blue and orange. (C) Multiple
sequence alignment of RhoE, Rnd1, Rnd2 and RhoA. Residues contacting ROCK-I are indicated by blue and green arrowheads, with blue
arrowheads showing mutated residues (Thr173, Val192). Red arrowheads denote residues of the effector region required for RhoE function.
Figure was produced using ALSCRIPT (Barton, 1993).
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in the related kinase ROCK-II (Yamaguchi et al, 2006) (data
not shown). However, in the isolated ROCK-I structure
(Jacobs et al, 2006), its participation in crystal packing
interactions most likely accounts for its non-canonical
conformation.
RhoE as a substrate of ROCK-I
The interaction of RhoE with ROCK-I positions RhoE to
present both its N and C termini in close proximity to the
kinase catalytic site cleft (Figure 5A). The visible N and C
termini of RhoE (residues 20 and 200, respectively) are
located some 20A ˚ from the kinase phosphoacceptor-binding
site. Model building studies, extending the polypeptide chain
N-terminal from Gln20, and with reference to the position of
the GSK3b peptide bound to PKBb (Yang et al, 2002), indicate
that both N-terminal phosphorylation sites, Ser7 and Ser11,
are within reach of the catalytic site (Figure 5A). Similarly,
the ﬁve phosphorylation sites within the C terminus are also
all capable of accessing the catalytic site. Although contig-
uous electron density bridging Gln20 of RhoE with the kinase
catalytic cleft is not observed, electron density (maps con-
toured at 3s) corresponding to the main-chain of the phos-
phoacceptor and adjacent P 1 and P 2 residues of a peptide
substrate modelled on GSK3b bound to PKBb (Yang et al,
2002) is visible in molecule A of the ROCK-I:RhoE complex
(Figure 5B). This electron density is consistent with partial,
and possibly alternate, occupancy of one or both phosphoac-
ceptor residues (Ser7 and Ser11) at the kinase catalytic cleft.
The relatively poorly resolved electron density at the catalytic
site of ROCK-I is not due to a disrupted catalytic site or
hindered access, as the structure of ROCK-I appears compa-
tible with catalysis and protein substrate recognition.
Supporting our conclusions, in a crystal structure of ROCK-I
with RhoE lacking its N terminus, which we determined at
the same resolution in the same space group, no electron
density is observed at the phosphoacceptor site (data not
shown).
Figure 4 Conformational changes of RhoE and ROCK-I on forming
a complex are conﬁned to the ROCK-I:RhoE interface. (A) RhoE
with comparison to isolated RhoE (Fiegen et al, 2002; Garavini et al,
2002) and RhoA structures (Ihara et al, 1998) and (B) stereoview of
ROCK-I, isolated ROCK-I from Jacobs et al (2006).
Figure 5 RhoE phosphorylation by ROCK-I. (A) View of the
ROCK-I:RhoE dimer with a substrate peptide based on GSK3b
bound to PKB (magenta) (Yang et al, 2002), modelled into the
catalytic cleft of ROCK-I. The distance between the visible N and C
termini of RhoE to the phosphoacceptor site in ROCK-I is 20A ˚.
Colour scheme as in Figure 2. (B) Details of the catalytic site of
ROCK-I, Fo–Fc electron density (contoured at 3s in green) over-
lapping a GSK3b peptide bound to PKB modelled into the ROCK-I
catalytic site.
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P 2 and/or P 3 (Amano et al, 1996; Kawano et al, 1999;
Hagerty et al, 2007), and all seven RhoE phosphorylation
sites conform to this consensus sequence (Supplementary
Figure S4A). However, relative to ROCK-I phosphorylation
sites in MYPT1 and ZIPK (Amano et al, 1996; Kawano et al,
1999; Hagerty et al, 2007) (Supplementary Figure S4B), RhoE
phosphorylation sites comprise fewer basic residues, poten-
tially attenuating their afﬁnity for the ROCK-I catalytic site.
The notion that optimised phosphorylation sites of ROCK-I
may require numerous N-terminal basic residues is supported
by analogy to the basophilic protein kinases PKA and PKB,
the substrates of which contain multiple basic residues at
sites P 2t oP  5 (Kennelly and Krebs, 1991; Alessi et al,
1996), and which, in common with ROCK-I, feature acidic
residues lining the N-terminal region of their substrate-bind-
ing clefts.
Kinase aG helix is a common module for substrate and
inhibitor recognition
The aG helix is a relatively exposed structural feature of the
C-lobe of protein kinases, and together with the proximal aEF
helix and aEF/aF loop, protrudes from the main body of the
molecule. In our ROCK-I:RhoE structure, the aG helix dom-
inates interactions with RhoE, inserting into the shallow
channel created by the RhoE a4–b6–a5 module, facilitating
a mode of kinase–protein interaction also observed in other
complexes (Supplementary Figure S5). The structure of the
ROCK-I:RhoE complex is strikingly reminiscent of the protein
substrate complex formed between the RNA-dependent pro-
tein kinase PKR and its substrate, eIF2a (Dar et al, 2005)
(Supplementary Figure S5A). As observed in our ROCK-
I:RhoE complex, eIF2a bound to PKR is disposed such that
its phosphoacceptor site is accessible to the kinase catalytic
site, although the site of eIF2a phosphorylated by PKR is not
resolved within the kinase catalytic site (Dar et al, 2005). In
CDK2, the aG helix, together with the C-terminal segment of
aEF, mediates the major site of interaction with its protein
phosphatase KAP, positioning the phosphatase catalytic site
optimally to contact and dephosphorylate pThr160 of the
CDK2 activation segment (Song et al, 2001) (Supplementary
Figure S5B). Lastly, in the PKA holoenzyme complex, the
cAMP-binding domain CBD-A of the regulatory RIa subunit
contacts both the aG and aEF helices of the catalytic subunit
to engage its inhibitor segment at the catalytic site cleft in a
mode reminiscent of a peptide substrate (Kim et al, 2005)
(Supplementary Figure S5C). Notably, a common feature of
these complexes is that protein interactions facilitated
through a secondary site of the kinase—the aG and aEF
helices—optimise contacts with the primary site of the acti-
vation segment, important for substrate recognition (Dar
et al, 2005), pseudo-substrate inhibition by regulatory sub-
units (Kim et al, 2005) and phosphatase catalysed depho-
sphorylation of the activation segment (Song et al, 2001).
RhoE binds to ROCK-I through a distinctive mechanism
In contrast to other G-protein:effector complexes, interactions
between RhoE and the kinase domain of ROCK-I are inde-
pendent of switches I and II (Vetter and Wittinghofer, 2001),
which are consequently accessible for potential interactions
with other domains of ROCK-I, possibly with sites within the
coiled-coil region, and/or with other proteins. Interestingly,
the involvement of the a4–b6–a5 module of a G protein as
observed in the ROCK-I:RhoE complex, is reminiscent of how
Ran contacts the acidic loop of importin/karyopherinb
(Chook and Blobel, 1999; Vetter et al, 1999). In the
karyopherinb:Ran complex (Chook and Blobel, 1999), a
portion of the acidic loop, a 60-residue insertion within
HEAT repeat 7, adopts a 310 helical conformation lying anti-
parallel to the b6 strand of Ran within its a4–b6–a5 channel.
However, karyopherinb also interacts with the effector region
of Ran, and not exclusively through the a4–b6–a5 channel.
Mutagenesis of the ROCK-I:RhoE interface prevents
binding and phosphorylation of RhoE by ROCK-I
To test whether disruption of the ROCK-I:RhoE interface
affects RhoE interaction with ROCK-I, RhoE amino acids
Thr173 and Val192 of the b6 strand and a5 helix, respectively,
were mutated to arginines. Although recombinant glu-
tathione-S-transferase (GST)–RhoE
WT interacted with ROCK-
I
1 420 from COS-7 cell lysates, GST–RhoE
T173R and
RhoE
V192R, as well as the double mutant RhoE
T173R/V192R,
were unable to pull down ROCK-I
1 420 (Figure 6A) or to
interact with puriﬁed ROCK-I
1 406 in vitro (Figure 6B), con-
ﬁrming the importance of these residues for the interaction of
RhoE with ROCK-I. The interaction between RhoE
WT and
ROCK-I
1 420 occurred in the absence of additional AMP-
PNP. Furthermore, in contrast to RhoE
WT, these mutants
were not phosphorylated when co-expressed with ROCK-
I
1 420 in COS-7 cells (Figure 6C). However, mutation of
effector site residues (Val56, Phe57 and Tyr60) did not inhibit
binding to ROCK-I
1 420 (Figure 6A and B) or ROCK-I phos-
phorylation of RhoE in cells (Figure 6C), consistent with the
lack of involvement of these effector residues in ROCK-I
interactions. Mutation of Ser288 to Arg and Asn292 to Asp
in the ROCK-I aG helix prevented interaction with wild-type
RhoE (Figure 6A) and these mutants were unable to phos-
phorylate RhoE in cells (Supplementary Figure S6).
ROCK-I:RhoE interaction is not required for
RhoE-induced loss of stress ﬁbres
To investigate whether RhoE interaction with ROCK-I is
necessary for its ability to alter actin organisation in cells,
RhoE mutants were expressed in HeLa and Swiss 3T3 cells.
Signiﬁcantly, the RhoE mutants RhoE
T173R and RhoE
V192R,
as well as the double mutant RhoE
T173R/V192R, induced
similar responses to wild-type RhoE in both cell types
(Figure 7A and B; Supplementary Figure S7A). All of these
mutants induced a strong reduction of stress ﬁbres in the
majority of HeLa cells, and a rounded phenotype with
branched protrusions (branching) in 30–40% of cells
(Figure 7A and B). Cells with a branched phenotype also
lacked stress ﬁbres, and this phenotype was generally in-
duced at higher levels of RhoE. In contrast, RhoE effector
domain mutants RhoE
V56Y and RhoE
F57A were defective in
their ability to stimulate loss of stress ﬁbres and cell round-
ing, and in some cells increased stress ﬁbre levels, suggesting
that they could function as dominant-negative RhoE mutants
(Figure 7A and B). Interestingly, the RhoE
Y60A mutant had a
similar phenotype to wild-type RhoE, indicating that this
amino acid (equivalent to Tyr40 in Ras and Rac) is not
necessary for RhoE-induced actin reorganisation. Similarly,
Tyr40 in Rac is not required for changes to the actin cytoske-
leton (Lamarche et al, 1996). The localisation of RhoE
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(Figure 7A). These results indicate that binding of a protein
to the RhoE effector region is important for RhoE-induced
loss of stress ﬁbres, rather than direct binding to ROCK-I,
which is independent of the effector site.
It is possible that other ROCK-I substrates employ a similar
interface as RhoE to bind the kinase. To test this possibility,
we expressed ROCK-I aG helix mutants in Swiss 3T3 cells.
Both ROCK-I
S288R (1–420) and ROCK-I
N292D (1–420) induce
stress ﬁbre bundling to form stellate arrays of stress ﬁbres,
similar to wild-type ROCK-I (1–420) (Supplementary
Figure S7B). The aG helix is therefore not essential for
ROCK-I binding to substrates required for acto-myosin
contractility, such as MYPT1 and MLC.
Discussion
The ROCK-I:RhoE structure provides insights into mechan-
isms of multi-site phosphorylation of an individual substrate
by a speciﬁc protein kinase. Consistent with the crystal
structure, mutations of RhoE within b6o ra5 that comprise
the ROCK-I-binding site abolished interactions with ROCK-I
in vitro. Furthermore, the same mutations, and those within
the aG helix of ROCK-I, abrogated ROCK-I-catalysed RhoE
phosphorylation in vivo. Interestingly, one of the ROCK-I
mutations defective for RhoE binding, a substitution of Asp
for Asn292, converts the RhoE-binding site of ROCK-I to that
of ROCK-II, demonstrating that this single amino-acid differ-
ence is sufﬁcient to prevent ROCK-II interactions with, and
subsequent ROCK-II-mediated phosphorylation of RhoE.
These ﬁndings indicate that the formation of a complex
between ROCK-I and RhoE involving the kinase aG helix,
representing a secondary site of interaction, is a prerequisite
for ROCK-I-catalysed phosphorylation of RhoE. This suggests
that the ROCK-I phosphorylation sites within the N and C
termini of RhoE are only presented to the kinase catalytic site
in the context of an interaction between the two proteins
mediated by the aG helix. We predict therefore that each of
the seven RhoE phosphorylation sites individually is poorly
optimised for ROCK-I phosphorylation. Within the context of
the crystal structure, the two ROCK-I phosphorylation sites
present in RhoE (Ser7 and Ser11) are likely interchanging at
the catalytic (primary binding) site, with resultant low sub-
strate occupancy and consequently disordered and poorly
resolved electron density. Conceivably, where a protein sub-
strate is presented to the catalytic site of its cognate kinase
through interactions to a secondary site, the context of the
phosphoacceptor site deviates from that required to optimise
Figure 6 Disruption of ROCK-I:RhoE interaction and effects on RhoE/ROCK-I responses. (A) The indicated wild-type (WT) and mutant GST–
RhoE proteins on glutathione beads were incubated with cell lysates from COS-7 cells transfected with pCAG-myc-ROCK-I
1 420 (wild-type and
indicated mutants). Proteins that bound to GST–RhoE were resolved by SDS–PAGE and western blotted with anti-myc antibody to identify
myc–ROCK-I. The lower panel (Coomassie staining of polyacrylamide gel) shows that equal amounts of each GST–RhoE mutant were used in
the binding assay. (B) GST–RhoE was incubated with His-ROCK-I puriﬁed from baculovirus-infected insect cells. ROCK-I bound to glutathione
agarose immobilised RhoE was identiﬁed by western blotting with anti-His antibody. (C) ROCK-I phosphorylation of RhoE in cells. COS-7 cells
were co-transfected with the indicated FLAG–RhoE and myc–ROCK-I
1 420 expression vectors. After 24h, cells were lysed and cell lysates were
western blotted with anti-FLAG antibody to detect RhoE. ROCK-I-phosphorylated RhoE migrates more slowly. ERK1 panels indicate equivalent
loading in each lane.
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secondary site contributes to the phosphorylation reaction.
Studies by Haystead and colleagues have indicated that
peptides modelled on ROCK-I phosphorylation sites of
MYPT1 and ZIPK are efﬁciently phosphorylated by the kinase
(Hagerty et al, 2007). In contrast to RhoE phosphorylation
sites, these optimised substrates feature multiple basic resi-
dues N-terminal to the phosphoacceptor site (Supplementary
Figure S4B).
Phosphorylation of suboptimal sites by a kinase presented
with a substrate bound through a secondary binding site is
reminiscent of phosphorylation in trans of non-consensus
sites within activation segments (Oliver et al, 2007; Wu et al,
2008). As mutations of the aG helix of ROCK-I do not prevent
Figure 7 Effect of RhoE mutants on the actin cytoskeleton. HeLa cells were transfected with the indicated FLAG–RhoE wild-type (WT) and
mutant constructs, or with empty vector (control). After 24h, cells were ﬁxed and stained for actin ﬁlaments and with anti-FLAG antibody. (A)
Representative images of transfected cells. Left panels of each pair of images show actin ﬁlaments (F-actin); cells expressing transfected FLAG
epitope-tagged RhoE are indicated with arrows, and were identiﬁed by staining with anti-FLAG antibody (right panels of each pair, labelled
‘RhoE’). Note that cells expressing transfected RhoE have much fewer stress ﬁbres than surrounding untransfected cells, except for cells
expressing V56Y and F57A mutants. (B) Cells expressing transfected RhoE were scored for loss of stress ﬁbres (compared with surrounding
untransfected cells) and for rounded,‘branching’ phenotype; 100 FLAG antibody-stained cells were counted on each of three coverslips; mean
% of cells in each category ±s.e.m. is shown. Note that the ‘branching’ phenotype is a stronger response to RhoE than loss of stress ﬁbres. (C)
Model for RhoE and ROCK-I regulation. RhoE exerts negative feedback regulation of ROCK-I. Stabilised RhoE (through RhoA-activated ROCK-I
phosphorylation or RhoE over-expression) antagonises RhoA-stimulation of ROCK-I through either activation of p190 RhoGAP or through
regulation of an alternative RhoA effector.
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induce stress ﬁbre formation and cell contraction, and that
MYPT1 is also a ROCK-II substrate, it is likely that MYPT1
does not utilise a secondary ROCK-I-binding site centred on
the aG helix.
The structure of the ROCK-I:RhoE complex provides a
molecular framework for testing the role of direct
RhoE:ROCK-I interactions in mediating RhoE-dependent
stress ﬁbre disassembly. Signiﬁcantly, those mutations of
RhoE that disrupt ROCK-I interactions have no effect on its
ability to disrupt actin stress ﬁbres in vivo. In contrast,
however, mutations within the effector region of RhoE pre-
vent loss of stress ﬁbres without affecting ROCK-I-mediated
RhoE phosphorylation. These data clearly demonstrate that
the ability of RhoE to induce loss of stress ﬁbres is indepen-
dent of its capacity to bind ROCK-I directly, suggesting that
RhoE either negatively regulates ROCKs through upstream
effectors, or interacts with other proteins to induce loss of
stress ﬁbres. The ﬁnding that high-level expression of RhoE
inhibits a constitutively active form of ROCK-I (Riento et al,
2003) is likely explained by substrate-level inhibition.
A potential candidate for a RhoE target is p190 RhoGAP. In
an earlier study, RhoE was found to stimulate p190 RhoGAP
activity, reducing cellular RhoA-GTP. An effector mutant of
RhoE (Thr55Ala) defective for p190 RhoGAP binding, was
unable to induce stress ﬁbre loss (Wennerberg et al, 2003).
However, in contrast to these ﬁndings, overexpression of
RhoE in Swiss 3T3 cells did not reduce RhoA-GTP levels
(Villalonga et al, 2004), indicating that an alternative RhoE
effector could be responsible for the inhibition of ROCK-I
signalling. One possibility is Socius, which binds to both
Rnd1 and RhoE and induces loss of stress ﬁbres (Katoh et al,
2002).
Our results indicate that the primary function of the ROCK-
I:RhoE interaction is to allow RhoE phosphorylation on
multiple sites. ROCK-I-catalysed phosphorylation of RhoE
stabilises the protein and correlates with disruption of actin
stress ﬁbres (Riento et al, 2005a). Stabilisation of RhoE
through ROCK-I activation might enable efﬁcient stimulation
of a RhoE effector resulting in a negative feedback loop
in vivo that then inhibits ROCK-I. Under conditions of RhoE
overexpression, such as in the p53-mediated DNA damage
response, or in transfection and microinjection experiments,
RhoE levels and stability are presumably sufﬁcient to activate
a RhoE effector and induce loss of stress ﬁbres without
phosphorylation by ROCK-I (Figure 7C).
In conclusion, the structure of a complex of RhoE bound to
ROCK-I, together with mutagenesis studies, has revealed that
the main function of the ROCK-I:RhoE interaction is to
mediate multi-site phosphorylation of RhoE. Multi-site phos-
phorylation is characterised by suboptimal phosphoacceptor
sites engaged at the primary catalytic site with afﬁnity and
speciﬁcity for the protein substrate augmented by a remote
secondary interaction site.
Materials and methods
Cloning and mutagenesis
pCAG-myc-ROCK-I
1 420 and pCMV-FLAG-RhoE have been described
earlier (Riento et al, 2003). ROCK-I
1 406 was cloned with an N-
terminal His tag into the pFastBac system for the generation of
baculovirus, and RhoE
1 200 were cloned into the pET28 vector for
bacterial expression. GST-tagged versions of RhoE generated using
the pGEX6 and pGEX4 vectors (GE Healthcare). Mutagenesis on
ROCK-I and RhoE was performed using the Quikchange system
(Stratagene).
Protein expression, puriﬁcation and crystallisation
His-tagged ROCK-I
1 406 was produced using baculovirus-mediated
insect cell expression in Sf9 cells, with 72h of infection at an MOI of
2. A cell pellet from 2.5l cells was lysed in lysis buffer A (300mM
NaCl, 50mM Tris (pH 8.0), 15mM imidazole, Complete protease
inhibitor) and after centrifugation (40min, 20000g) was applied to
15ml TALON resin. The His-tagged protein was eluted using lysis
buffer supplemented with 150mM imidazole at pH 7, and the His
tag was cleaved using 100mg His-TEV protease overnight during
dialysis into buffer A (100mM NaCl, 25mM Tris (pH 7.5) and 1mM
DTT). ROCK-I was further puriﬁed by anion exchange and gel
ﬁltration in buffer B (200mM NaCl, 20mM Tris (pH 7.5) and 1mM
DTT). RhoE
1 200 was expressed in Escherichia coli strain BL21 with
an N-terminal His6 tag, and puriﬁed according to Garavini et al
(2002).
RhoE was mixed with ROCK-I in a 3:1 molar ratio, 5mM AMP-
PNP and 10mM MgCl2 was added, the mixture was concentrated to
6mg/ml, and used in crystallisation screening. Hexagonal plate
crystals were obtained from 0.6 to 1M Na/K tartrate, 0.1M MES
(pH 5–6) and 0.2M LiSO4. Prior to data collection, crystals were
soaked brieﬂy in mother liquor containing 20% (v/v) ethylene
glycol, and frozen.
Data collection, structure solution and reﬁnement
Diffraction data for the ROCK-I:RhoE complex were collected at the
ESRF beamline ID29. The crystals displayed a hexagonal lattice
(point group P622) and diffracted to a maximum of 3.7A ˚ with only
few crystals showing useable diffraction. Owing to a long cell axis
(c¼532A ˚), oscillation angles of 0.251 were collected. Indexing of
different crystals, where possible, revealed large deviations in the
long cell axis, eliminating the possibility of merging datasets from
different crystals. Furthermore, crystals suffered from radiation
damage during data collection. The structure was solved by
molecular replacement in PHASER (McCoy et al, 2007), using the
structure of ROCK-I (pdb-id 2etr) and the structure of RhoE (1gwn)
as search models. Despite the large unit cell, PHASER identiﬁed just
two copies of both ROCK-I and RhoE, and unambiguously
determined the space group as P6522. Inspection of the packing
and the resulting map veriﬁed the solution; this determines a
Matthews coefﬁcient of 6.3 (80.5% solvent content), possibly
explaining the observed intrinsic resolution limit of the crystals.
Molecular replacement statistics are listed in Supplementary Figure
S2B. Calculations of electron density maps using phases based on
the ROCK-I model alone, revealed additional electron density
adjacent to the ROCK-I aG helix consistent with the position of
RhoE determined using molecular replacement (Supplementary
Figure S2C).
The structure was reﬁned with PHENIX (Adams et al, 2002),
initially using simulated annealing to overcome model bias. Non-
crystallographic symmetry restraints were applied on chains of
ROCK-I and RhoE individually. The maps are of exceptional quality
for the given resolution, and several loops that were initially
removed could be rebuilt, and additional residues lacking in the
search models could be included in subsequent rounds of model
building using COOT (Emsley and Cowtan, 2004). Electron density
was present for AMP-PNP/Mg
2þ in the kinase domain and GTP/
Mg
2þ bound to RhoE, and both ligands were reﬁned with full
occupancy (Supplementary Figure S2C and S2D). The models of
ROCK-I lack interpretable electron density for residues 1–5 and 372–
377 (molecule A) or 372–374 (molecule C). RhoE residues 1–19
were missing in the electron density (see Results). Complete data
collection and reﬁnement statistics can be found in Table I.
COS-7 cell transfections and GST–RhoE pull downs
COS-7 cells were grown in Dulbecco’s modiﬁed Eagle’s medium
(DMEM) containing 10% fetal calf serum (FCS). For transfection
with constructs encoding myc epitope-tagged ROCK-I and/or FLAG
epitope-tagged RhoE, cells were washed with 5ml of cold
electroporation buffer (120mM KCl, 10mM K2PO4 KH2PO4 (pH
7.6), 25mM HEPES (pH 7.6), 2mM MgCl2 and 0.5% Ficoll). The
buffer was removed and cells were resuspended in 250ml of cold
electroporation buffer and electroporated at 250V and 960mF with
5mg of DNA. Cells were then incubated for 24h prior to lysis.
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expressed as GST fusion proteins in E. coli and puriﬁed as described
earlier (Riento et al, 2003). Recombinant GSTwas used as a control.
Transfected COS-7 cells were washed and lysed in lysis buffer (1%
Triton X-100, 20mM Tris–HCl (pH 8), 130mM NaCl, 10mM NaF,
1% aprotonin, 10mg/ml leupeptin, 1mM DTT, 0.1mM Na3VO4 and
1mM PMSF). Insoluble material was removed by centrifugation and
the clariﬁed cell lysates were incubated with rotation for 2h at 41C
with the recombinant GST fusion proteins on glutathione-sepharose
beads (30ml). Beads were washed extensively with lysis buffer and
then the proteins were eluted in Laemmli sample buffer. Western
blotting to indicate the presence of bound ROCK-I was performed as
described in Garg et al (2008).
In vitro pull-down experiments
GST-tagged RhoE proteins were expressed in E. coli BL21 cells as for
crystallisation. GST–RhoE was puriﬁed by afﬁnity puriﬁcation (GSH
sepharose 4B; GE Healthcare) in lysis buffer B (270mM sucrose,
150mM NaCl, 50mM Tris (pH 8), 1mM EGTA, 10mM MgCl2 and
10 mM b-mercaptoethanol). The resin was washed extensively, and
GST-tagged RhoE proteins were eluted with lysis buffer B plus
30mM glutathione.
For pull-down experiments, 30mg of GST–RhoE was incubated
with 30ml GSH-sepharose 4B equilibrated in pull-down buffer (PDB:
150mM NaCl, 50mM Tris (pH 7.6), 0.1 % NP-40 and 5mM DTT)
supplemented with 1mg/ml bovine serum albumin (BSA). After 1h
incubation at 41C with agitation, the resin was washed 4  with
PDB, and incubated with PDBþBSA with 0.1mg/ml His6-ROCK-I
(puriﬁed for crystallisation without cleavage of the His6 tag)
overnight at 41C. The resin was then washed six times with PDB,
mixed with SDS sample buffer and resolved on SDS–PAGE. Western
blotting with aHis-HRP (Sigma-Aldrich) was used to reveal RhoE-
bound ROCK-I.
Analysis of actin cytoskeleton
HeLa and Swiss 3T3 cells were grown in DMEM containing 10%
FCS. For transfection, 6 10
5 HeLa cells were seeded onto 60-mm
Petri dishes and plasmids encoding FLAG epitope-tagged RhoE
wild-type or point mutants (2.5mg) were transfected in serum-free
OptiMEM medium using Lipofectamine 2000 (Invitrogen) according
to the manufacturer’s instructions. Fresh serum-containing medium
was added after 4h. After transfection, cells were incubated for
24h. For microinjection, Swiss 3T3 cells were seeded on coverslips
at 3 10
4 cells/ml. Cells were microinjected with 100ng/mlo f
FLAG–RhoE or myc–ROCK-I expression vectors. After microinjec-
tion, cells were incubated for 6h to allow expression of proteins.
HeLa and Swiss 3T3 cells were then ﬁxed with 3.7% formaldehyde
solution, permeabilised with 0.2% Triton X-100 in PBS and stained
for actin ﬁlaments (F-actin) with 0.1mg/ml TRITC-labeled phalloi-
din (Sigma-Aldrich) and for RhoE or ROCK-I expression with rabbit
anti-FLAG antibody (Sigma) or mouse anti-myc (9E10) antibody
(Santa Cruz Biotechnology), followed by ﬂuorescein isothiocya-
nate-conjugated goat anti-mouse or goat–anti-rabbit antibodies
(Jackson Immunoresearch). Coverslips were mounted in Dako
mounting ﬂuid (Dako Cytometrics) and images were generated with
a Zeiss LSM Exciter or LSM510 confocal microscope using a  40/
1.3 NA objective. To quantify RhoE-induced loss of stress ﬁbres and
acquisition of a rounded ‘branching’ phenotype in HeLa cells, 10
random images of cells were generated by confocal microscopy
from each of three coverslips, and FLAG antibody-stained cells were
scored for loss of stress ﬁbres (compared with surrounding
uninjected cells) and for ‘branching’ phenotype. Note that cells
with the ‘branching’ phenotype were not included in the ‘no stress
ﬁbre’ category.
Supplementary data
Supplementary data are available at The EMBO Journal Online
(http://www.embojournal.org).
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